Aligos Therapeutics Inc (ALGS)’s financial ratios: A comprehensive overview

In other words, the price has increased by $0.0000 from its previous closing price. On the day, 1289882 shares were traded.

Ratios:

For a better understanding of ALGS, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.90 and its Current Ratio is at 5.90. In the meantime, Its Debt-to-Equity ratio is 0.12 whereas as Long-Term Debt/Eq ratio is at 0.09.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Piper Sandler on January 06, 2023, Upgraded its rating to Overweight and sets its target price to $3 from $2 previously.

On January 06, 2023, Jefferies Upgraded its rating to Buy which previously was Hold and also upped its target price recommendation from $2.50 to $3.

Piper Sandler Downgraded its Overweight to Neutral on March 23, 2022, whereas the target price for the stock was revised from $15 to $4.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Oct 25 ’23 when Nuechterlein Carole bought 7,933,601 shares for $0.76 per share. The transaction valued at 6,004,149 led to the insider holds 11,025,941 shares of the business.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALGS now has a Market Capitalization of 65.83M and an Enterprise Value of -58.73M. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.38 while its Price-to-Book (P/B) ratio in mrq is 0.71. Its current Enterprise Value per Revenue stands at -3.78 whereas that against EBITDA is 0.69.

Stock Price History:

Over the past 52 weeks, ALGS has reached a high of $1.51, while it has fallen to a 52-week low of $0.54. The 50-Day Moving Average of the stock is 0.7625, while the 200-Day Moving Average is calculated to be 0.8147.

Shares Statistics:

Over the past 3-months, ALGS traded about 373.31K shares per day on average, while over the past 10 days, ALGS traded about 543.59k shares per day. A total of 72.00M shares are outstanding, with a floating share count of 52.70M. Insiders hold about 32.60% of the company’s shares, while institutions hold 49.53% stake in the company. Shares short for ALGS as of Feb 29, 2024 were 369.07k with a Short Ratio of 0.99, compared to 894.47k on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 0.49% and a Short% of Float of 0.54%.

Earnings Estimates

Current recommendations for the stock of the company come from 2 analysts. On average, analysts expect EPS of -$0.17 for the current quarter, with a high estimate of -$0.15 and a low estimate of -$0.19, while EPS last year was -$0.53. The consensus estimate for the next quarter is -$0.18, with high estimates of -$0.15 and low estimates of -$0.21.

Analysts are recommending an EPS of between -$0.6 and -$0.84 for the fiscal current year, implying an average EPS of -$0.72. EPS for the following year is -$0.74, with 2 analysts recommending between -$0.5 and -$0.99.

Most Popular

[the_ad id="945"]